» Articles » PMID: 9753452

Localization of the Sites for Ca2+-binding Proteins on G Protein-coupled Receptor Kinases

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1998 Sep 30
PMID 9753452
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Inhibition of G protein-coupled receptor kinases (GRKs) by Ca2+-binding proteins has recently emerged as a general mechanism of GRK regulation. While GRK1 (rhodopsin kinase) is inhibited by the photoreceptor-specific Ca2+-binding protein recoverin, other GRKs can be inhibited by Ca2+-calmodulin. To dissect the mechanism of this inhibition at the molecular level, we localized the GRK domains involved in Ca2+-binding protein interaction using a series of GST-GRK fusion proteins. GRK1, GRK2, and GRK5, which represent the three known GRK subclasses, were each found to possess two distinct calmodulin-binding sites. These sites were localized to the N- and C-terminal regulatory regions within domains rich in positively charged and hydrophobic residues. In contrast, the unique N-terminally localized GRK1 site for recoverin had no clearly defined structural characteristics. Interestingly, while the recoverin and calmodulin-binding sites in GRK1 do not overlap, recoverin-GRK1 interaction is inhibited by calmodulin, most likely via an allosteric mechanism. Further analysis of the individual calmodulin sites in GRK5 suggests that the C-terminal site plays the major role in GRK5-calmodulin interaction. While specific mutation within the N-terminal site had no effect on calmodulin-mediated inhibition of GRK5 activity, deletion of the C-terminal site attenuated the effect of calmodulin on GRK5, and the simultaneous mutation of both sites rendered the enzyme calmodulin-insensitive. These studies provide new insight into the mechanism of Ca2+-dependent regulation of GRKs.

Citing Articles

A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure.

Coleman R, Eguchi A, Lieu M, Roy R, Barr E, Ibetti J Sci Signal. 2021; 14(676).

PMID: 33785612 PMC: 8092419. DOI: 10.1126/scisignal.abb5968.


Structure of a GRK5-Calmodulin Complex Reveals Molecular Mechanism of GRK Activation and Substrate Targeting.

Komolov K, Sulon S, Bhardwaj A, van Keulen S, Duc N, Laurinavichyute D Mol Cell. 2020; 81(2):323-339.e11.

PMID: 33321095 PMC: 7855534. DOI: 10.1016/j.molcel.2020.11.026.


GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.

Cheng J, Klei L, Hubel N, Zhang M, Schairer R, Maurer L J Clin Invest. 2020; 130(2):1036-1051.

PMID: 31961340 PMC: 6994119. DOI: 10.1172/JCI97040.


Perturbation of the interactions of calmodulin with GRK5 using a natural product chemical probe.

Beyett T, Fraley A, Labudde E, Patra D, Coleman R, Eguchi A Proc Natl Acad Sci U S A. 2019; 116(32):15895-15900.

PMID: 31337679 PMC: 6689901. DOI: 10.1073/pnas.1818547116.


G protein-coupled receptor kinases: Past, present and future.

Komolov K, Benovic J Cell Signal. 2017; 41:17-24.

PMID: 28711719 PMC: 5722692. DOI: 10.1016/j.cellsig.2017.07.004.